The Friedreich's Ataxia Global Patient Registry is the only worldwide registry of Friedreich’s ataxia patients. For an FAQ about the registry, please click here.
This registry currently holds the demographic and clinical information on more than 3,400 Friedreich’s ataxia patients from across the United States and internationally. This registry was created to serve the patient, physician, and research communities.
New therapies for Friedreich Ataxia are in clinical trials with encouraging results and giving real hope for people living with FA today. Individuals with FA should enroll online in the FA Global Patient Registry to ensure that they receive a recruitment notice for any trial which they appear to be eligible:
NOTICE: The FA Patient Registry will be transitioning to a new site. This registry site will be temporarily shut down on Friday, Oct. 25th, and will be inaccessible for approximately 10 days. You will receive notification from the registry coordinator when the new FA Global Patient Registry is available for access. Thank you for your patience during this transition.
Participation in the FA Global Patient Registry ensures that patients are informed about opportunities to participate in clinical research studies and kept up-to-date on the progress of clinical trials. Physicians can refer their FA patients to the patient registry so that he/she can consider registering. This is a simple online registry that individuals can complete themselves, however it is helpful if individuals have a copy of their genetic test results so that they are able to enter information about confirmation of diagnosis.
The homepage of the FA Global Patient Registry website, www.curefa.net/registry, is a place that you can go to find an up-to-date listing of ongoing clinical trials for FA. You can refer your FA patients to the patient registry so that he/she can consider registering. FARA can provide you with registry brochures that you can give your patients to assist with the referral process.
The FA Global Patient Registry is a patient recruitment and communications tool for both academic and industry sponsored clinical research studies and trials. The registry coordinator can perform queries based on the inclusion/ exclusion criteria of a study and send patients information about a study for which they qualify. Patients can be contacted by the registry coordinator via e-mail, mail, or by telephone. Informational postings can also be added to the registry homepage as well as the FARA website and in the FARA newsletter. FARA is committed to assisting researchers with study recruitment and participation.
Opportunities to communicate with the patient community over time, while maintaining patient confidentiality
Enhanced patient recruitment through targeted recruitment notices to patients who best match the key inclusion/exclusion criteria for clinical research studies and trials
Pre-study planning - Information on the size of the FA patient population based on demographic features (e.g., age or geographic area) or clinical features (e.g. ambulation status).